Searched for
MOLBIO DIAGNOSTICS SHARE PRICE TARGET
World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor roundMolbio Diagnostics raised Rs 281 crore from anchor investors, including World Bank Group's IFC and HDFC Mutual Fund, ahead of its Rs 940 cr...- Rs 7,681 crore IPO rush: Shiprocket, Milky Mist among 9 issues to hit the marketIndia’s primary market is set for a busy week, with nine companies aiming to raise a combined Rs 7,681 crore through IPOs across the mainbo...
- Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPOMolbio Diagnostics has successfully attracted Rs 281.5 crore from anchor investors ahead of its much-anticipated initial public offering. T...
- Samvardhana Motherson shares rally over 7% after Q1 earnings; Motilal Oswal, Nomura weigh inSamvardhana Motherson International shares surged after the company posted record Q1 FY27 revenue of ₹35,244 crore (up 17% YoY) and a 70.1%...
- Swiggy shares jump nearly 3% as company targets Rs 10,000 crore adjusted EBITDA by FY31Swiggy shares rose after the company unveiled an ambitious FY31 roadmap targeting Rs 10,000 crore in Adjusted EBITDA. It aims to more than ...
- F&O Radar: Call Ratio Spread strategy for Dixon this weekDixon Technologies demonstrates a robust bullish technical structure on the daily charts, trading above key EMAs with RSI at 63.27. Choice ...
- Molbio diagnostics' Rs 940 crore initial public offering opens August 10The initial public offering price range for Molbio Diagnostics has been established, with a target of raising ₹940 crore. Subscription will...
- ICICI Bank, Bajaj Finance among Axis Securities’ top 8 largecap stock picks for AugustBenchmark indices witnessed broad-based gains, with leadership gradually shifting back towards largecap stocks. Here are the top eight larg...
- Molbio Diagnostics IPO to open on August 10, price band set at Rs 768-807Molbio Diagnostics is set to launch its IPO on August 10, 2026, with a price band of Rs 768-807 per share. The Rs 939.70 crore public issue...
- Buy, Sell or Hold: Nuvama maintains a buy on NYKAA and Uno Minda; Elara Securities recommends buy on Godrej PropertiesBrokerages remain bullish on select consumer, auto component, and real estate stocks. Nuvama reiterated 'Buy' on Nykaa (target Rs 414) and ...
- KEI Industries among 6 stocks showing bullish RSI upswingSix Nifty500 stocks, including KEI Industries, SAIL, and Delhivery, featured in the RSI Trending Up scan on 4 August after gaining over 2 p...
- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyFrom AI-powered hospitals and genomics to regenerative medicine and precision cardiology, ET Health Conclave 2026 brought together India's ...
- Buy, Sell or Hold: Goldman Sachs maintains buy rating on Jindal Stainless; Citi recommends sell call on BioconIGI: Morgan Stanley stays bullish, citing strong certification-market growth and the company’s shift toward a consumer-focused business.Jin...
- ITC shares gain 3% after Q1 results. Here’s why Nomura upgraded the stock to BuyITC share Price: ITC shares rose 2% after the FMCG major reported June-quarter results, despite a 27% YoY decline in standalone net profit....
- Redington shares gain 4% after Q1 profit jumps 77% YoY, revenue growth remains robustRedington shares gained nearly 4% after a 15% surge in the previous session, following a strong Q1FY27 performance. The technology solution...
- Swiggy shares plunge 6% even as losses narrow. Should investors buy, sell or accumulate?Swiggy Share Price: Swiggy shares plunged as much as 6% after the food delivery and quick commerce company reported its June-quarter result...
- Buy, Sell or Hold: Elara Capital downgrades Swiggy; Morgan Stanley remains overweight on M&MTop brokerages issued fresh stock views following mixed Q1 FY27 earnings. Elara Capital downgraded Swiggy to Accumulate with a target of Rs...
- BlueStone Jewellery shares soar 7%. Should you buy at current levels or avoid?BlueStone Jewellery and Lifestyle shares surged nearly 7%, extending their one-month rally to around 50% after robust Q1 FY27 earnings. The...
- Ambuja Cements share price target: Nuvama, Motilal, other brokerages see up to 30% upside. Here's whyAmbuja Cements shares rose over 1% despite reporting a 34% YoY decline in Q1 FY27 consolidated net profit to Rs 577 crore. Revenue fell 7.5...
- Time to re-look at a not-so-glamorous part of healthcare ecosystem: 4 diagnostics stocks with upside potential of up to 18%When companies from a sector with a clear growth path get listed, too much money flows into them, sending valuations high. What follows is ...
Load More
